Beta Drugs Limited — Important, 26-12-2024: Updates

BDL has announced its plan to migrate to the Main Board of both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). This strategic move aligns with the company's long-term growth objectives, aimed at enhancing liquidity and visibility while expanding its investor base, especially within the institutional sector. The migration process is expected to be completed by the end of the current financial year, contingent upon necessary approvals and compliance. This decision underscores BDL's commitment to strengthening its market position, and the company is optimistic that this transition will present greater opportunities for investors and assist in achieving its business goals more effectively.